April 25th 2024
Coverage from the Community Oncology Alliance Community Oncology Conference, held April 4-5, 2024, in Orlando, Florida.
Applying Accountable Care to Oncology: Developing an Oncology ACO
May 7th 2013The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.
Read More
Bundled Payment: Practice Savior or Killer?
May 7th 2013As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.
Read More
Vandana Abramson, MD, Addresses Treatment Strategies for Metastatic Breast Cancer
May 6th 2013In this video, Vandana Abramson, MD, assistant professor of medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, discusses the various strategies utilized in the treatment of metastatic breast cancer.
Read More
Vandana Abramson, MD, Addresses Treatment Strategies for Metastatic Breast Cancer
May 3rd 2013In this video, Vandana Abramson, MD, assistant professor of medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, discusses the various strategies utilized in the treatment of metastatic breast cancer.
Read More
More Comprehensive Discussion of CRC Screening Associated With Higher Screening
More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.
Read More
The Growing Cost of Specialty Pharmacy-Is it Sustainable?
February 18th 2013We only have to take a brief look back to see that 10 years ago, most specialty drugs were injectable agents used to treat conditions such as rheumatoid arthritis, multiple sclerosis, and growth disorders. Today, the list of agents that is considered specialty includes many oral drugs and even some inhaled agents. In just more than 2 decades, the specialty drug market place has grown substantially.
Read More
Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Read More